S

Sophia Genetics SA
NASDAQ:SOPH

Watchlist Manager
Sophia Genetics SA
NASDAQ:SOPH
Watchlist
Price: 4.54 USD -1.52% Market Closed
Updated: May 19, 2024

P/E
Price to Earnings

-4.1
Current
-3.9
Median
24.1
Industry
Lower than median
Lower than industry value

Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.

P/E
-4.1
=
Market Cap
296.8m
/
Net Income
-73m
All Countries
All Countries
Close
Earnings Growth
CH
S
Sophia Genetics SA
NASDAQ:SOPH
Average P/E: 75.7
Negative Multiple: -4.1 		N/A
US
Veeva Systems Inc
NYSE:VEEV
64.5
140%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
175.2
119%
JP
M3 Inc
TSE:2413
24.2
N/A
US
Doximity Inc
NYSE:DOCS
35.4
61%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -292.6 N/A
SE
Sectra AB
STO:SECT B
107.5
56%
US
Goodrx Holdings Inc
NASDAQ:GDRX
Negative Multiple: -426.4 N/A
US
Vocera Communications Inc
NYSE:VCRA
Negative Multiple: -324 N/A

P/E Forward Multiples

Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
P/E
hidden
2-Years Forward
P/E
hidden
3-Years Forward
P/E
hidden

See Also

Summary
SOPH intrinsic value, competitors valuation, and company profile.
DCF Valuation
SOPH stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SOPH stock valuation using valuation multiples.
Wall Street Estimates
SOPH price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SOPH stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.